Somers, Klaartje http://orcid.org/0000-0003-2741-3852
Evans, Kathryn
Cheung, Leanna
Karsa, Mawar
Pritchard, Tara
Kosciolek, Angelika
Bongers, Angelika
El-Ayoubi, Ali
Forgham, Helen
Middlemiss, Shiloh
Mayoh, Chelsea http://orcid.org/0000-0002-6398-3046
Jones, Luke
Gupta, Mahima
Kees, Ursula R.
Chernova, Olga
Korotchkina, Lioubov
Gudkov, Andrei V.
Erickson, Stephen W.
Teicher, Beverly
Smith, Malcolm A.
Norris, Murray D.
Haber, Michelle
Lock, Richard B.
Henderson, Michelle J.
Funding for this research was provided by:
Cancer Australia (APP1164865, APP1164865)
Anthony Rothe Memorial Trust
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA199222, CA199000, CA199222, CA199000, CA199222, CA199000)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Cancer Council NSW (PG16-01)
Article History
Received: 30 May 2019
Revised: 21 November 2019
Accepted: 5 December 2019
First Online: 17 December 2019
Conflict of interest
: AVG is a consultant of and OC, MG, and LK are employed by Oncotartis, Inc. which developed and holds the IP on OT-82.